Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Using two instead of three or four drugs could potentially lead to cost savings in the billions.
Aging, weight gain and efavirenz use were all associated with lower free testosterone levels in men living with HIV.
Preterm birth and low birthweights were more common among infants born to women with HIV, but the infants were no more likely to die.
But people with HIV are less likely to be diagnosed and treated for insomnia than their HIV-negative peers.
Compared with efavirenz-based regimens, dolutegravir-containing ones resulted in fewer switches and better viral control.
A 30-year retrospective review of abnormalities among infants born to women using antiretrovirals shows low, consistent levels.
Study results confirm that dolutegravir is a safe and effective treatment for pregnant women with HIV.
This finding among sub-Saharan Africans is quite concerning since dolutegravir is now the preferred first-line HIV treatment worldwide.
A 2018 report had suggested that HIV-positive women’s use of the drug at conception increased the risk of the rare birth defects.
Studies have found that weight gain is common after people with HIV begin an antiretroviral in this class.
The FDA approves three new, cheaper combination ARV tablets.
The tablet contains the same combo as Symfi Lo (efavirenz/lamivudine/tenofovir disoproxil fumarate) but with a higher dose of efavirenz.
Symfi Lo contains efavirenz, lamivudine and tenofovir disoproxil fumarate (TDF); Cimduo contains TDF and lamivudine.
Long-term Viread (tenofovir disoproxil fumarate, or TDF) use is linked with a raised risk of end-stage liver cancer in HIV-positive people.
The most effective birth control methods for women with HIV are implants and injectable hormonal contraceptives.
An updated version of Viread (tenofovir) offers slightly better viral suppression and improves indicators of kidney and bone health...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.